129 related articles for article (PubMed ID: 1694880)
1. Stimulation in vitro of lymphocytes for induction of uveoretinitis without any significant proliferation.
Kotake S; Wiggert B; Zhang XY; Redmond TM; Chader GJ; Gery I
J Immunol; 1990 Jul; 145(2):534-9. PubMed ID: 1694880
[TBL] [Abstract][Full Text] [Related]
2. Unusual immunologic properties of the uveitogenic interphotoreceptor retinoid-binding protein-derived peptide R23.
Kotake S; Redmond TM; Wiggert B; Vistica B; Sanui H; Chader GJ; Gery I
Invest Ophthalmol Vis Sci; 1991 Jun; 32(7):2058-64. PubMed ID: 2055698
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the pivotal residues of the immunodominant and highly uveitogenic determinant of interphotoreceptor retinoid-binding protein.
Kotake S; de Smet MD; Wiggert B; Redmond TM; Chader GJ; Gery I
J Immunol; 1991 May; 146(9):2995-3001. PubMed ID: 1707928
[TBL] [Abstract][Full Text] [Related]
4. Dissociation between lymphocyte activation for proliferation and for the capacity to adoptively transfer uveoretinitis.
Fox GM; Redmond TM; Wiggert B; Kuwabara T; Chader GJ; Gery I
J Immunol; 1987 May; 138(10):3242-6. PubMed ID: 3106477
[TBL] [Abstract][Full Text] [Related]
5. Orally induced bystander suppression in experimental autoimmune uveoretinitis occurs only in the periphery and not in the eye.
Wildner G; Thurau SR
Eur J Immunol; 1995 May; 25(5):1292-7. PubMed ID: 7774632
[TBL] [Abstract][Full Text] [Related]
6. Recognition of peptides that are immunopathogenic but cryptic. Mechanisms that allow lymphocytes sensitized against cryptic peptides to initiate pathogenic autoimmune processes.
Lipham WJ; Redmond TM; Takahashi H; Berzofsky JA; Wiggert B; Chader GJ; Gery I
J Immunol; 1991 Jun; 146(11):3757-62. PubMed ID: 1709661
[TBL] [Abstract][Full Text] [Related]
7. Serial adoptive transfer of experimental autoimmune uveoretinitis in rats.
Hu LH; Sanui H; Wiggert B; Redmond TM; Chan CC; Chader GJ; Gery I
Invest Ophthalmol Vis Sci; 1990 Jul; 31(7):1409-12. PubMed ID: 2365573
[TBL] [Abstract][Full Text] [Related]
8. Identification of a new epitope of human IRBP that induces autoimmune uveoretinitis in mice of the H-2b haplotype.
Avichezer D; Silver PB; Chan CC; Wiggert B; Caspi RR
Invest Ophthalmol Vis Sci; 2000 Jan; 41(1):127-31. PubMed ID: 10634611
[TBL] [Abstract][Full Text] [Related]
9. Evidence for selective accumulation of V beta 8+ T lymphocytes in experimental autoimmune uveoretinitis induced with two different retinal antigens.
Egwuagu CE; Mahdi RM; Nussenblatt RB; Gery I; Caspi RR
J Immunol; 1993 Aug; 151(3):1627-36. PubMed ID: 8393049
[TBL] [Abstract][Full Text] [Related]
10. Antigen-specific suppressor cells induced by FK506 in experimental autoimmune uveoretinitis in the rat.
Kawashima H; Fujino Y; Mochizuki M
Invest Ophthalmol Vis Sci; 1990 Dec; 31(12):2500-7. PubMed ID: 1702408
[TBL] [Abstract][Full Text] [Related]
11. Identification of a major pathogenic epitope in the human IRBP molecule recognized by mice of the H-2r haplotype.
Silver PB; Rizzo LV; Chan CC; Donoso LA; Wiggert B; Caspi RR
Invest Ophthalmol Vis Sci; 1995 Apr; 36(5):946-54. PubMed ID: 7706044
[TBL] [Abstract][Full Text] [Related]
12. A pathogenic autoimmune process targeted at a surrogate epitope.
Kozhich AT; Kawano Y; Egwuagu CE; Caspi RR; Maturi RK; Berzofsky JA; Gery I
J Exp Med; 1994 Jul; 180(1):133-40. PubMed ID: 7516403
[TBL] [Abstract][Full Text] [Related]
13. [Unique immunological properties of short forms of the interphotoreceptor retinoid-binding protein derived uveitogenic peptide].
Kotake S; Sanui H; Gery I
Nippon Ganka Gakkai Zasshi; 1992 May; 96(5):600-5. PubMed ID: 1377867
[TBL] [Abstract][Full Text] [Related]
14. Adoptive transfer of experimental autoimmune uveoretinitis induced by interphotoreceptor retinoid-binding protein.
Kawashima H; Fujiño Y; Mochizuki M
Jpn J Ophthalmol; 1991; 35(1):51-60. PubMed ID: 1895569
[TBL] [Abstract][Full Text] [Related]
15. Uveitogenicity is associated with a Th1-like lymphokine profile: cytokine-dependent modulation of early and committed effector T cells in experimental autoimmune uveitis.
Xu H; Rizzo LV; Silver PB; Caspi RR
Cell Immunol; 1997 May; 178(1):69-78. PubMed ID: 9184700
[TBL] [Abstract][Full Text] [Related]
16. Oral tolerance in experimental autoimmune uveoretinitis. Distinct mechanisms of resistance are induced by low dose vs high dose feeding protocols.
Gregerson DS; Obritsch WF; Donoso LA
J Immunol; 1993 Nov; 151(10):5751-61. PubMed ID: 7693817
[TBL] [Abstract][Full Text] [Related]
17. A new procedure for experimental autoimmune uveitis with small uveitogenic peptides.
Sery TW; Su YH; Eagle R; Ueda M; Yamamoto N
Ocul Immunol Inflamm; 2006 Oct; 14(5):277-83. PubMed ID: 17056461
[TBL] [Abstract][Full Text] [Related]
18. Uveitogenic potential of lymphocytes sensitized to interphotoreceptor retinoid-binding protein.
McAllister CG; Wiggert B; Chader GJ; Kuwabara T; Gery I
J Immunol; 1987 Mar; 138(5):1416-20. PubMed ID: 3805723
[TBL] [Abstract][Full Text] [Related]
19. Immunomodulation of experimental autoimmune uveoretinitis by intravenous injection of uveitogenic peptides.
Sasamoto Y; Kawano YI; Bouligny R; Wiggert B; Chader GJ; Gery I
Invest Ophthalmol Vis Sci; 1992 Aug; 33(9):2641-9. PubMed ID: 1639611
[TBL] [Abstract][Full Text] [Related]
20. Repertoire analysis and new pathogenic epitopes of IRBP in C57BL/6 (H-2b) and B10.RIII (H-2r) mice.
Cortes LM; Mattapallil MJ; Silver PB; Donoso LA; Liou GI; Zhu W; Chan CC; Caspi RR
Invest Ophthalmol Vis Sci; 2008 May; 49(5):1946-56. PubMed ID: 18436827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
